Other Income, mainly grant income, increased to EUR 1.7M (2023: EUR 0.5M). In 2024, the Company successfully negotiated an amendment with the European Innovation Council and was able to secure ...
Onward Holdings Co., Ltd. ( ($JP:8016) ) has shared an update. Onward Holdings Co., Ltd. has announced the transfer of non-current assets from its ...
The latest announcement is out from Onward Holdings Co., Ltd. ( ($JP:8016) ). In October 2025, Onward Holdings Co., Ltd. reported an increase in ...
EPALINGES, Switzerland, Oct. 27, 2025 /PRNewswire/ -- Onward Therapeutics SA, a clinical stage oncology company, today announced that its French subsidiary, Onward Therapeutics France, has exercised ...
EPALINGES, Switzerland and PARIS, April 22, 2025 /PRNewswire/ -- Onward Therapeutics SA, a biotechnology company dedicated to advancing innovative cancer immunotherapies, announced that its subsidiary ...
Groundbreaking procedures extend ONWARD’s leadership in the rapidly emerging brain-computer interface (BCI) field ARC-BCI Therapy is designed to restore thought-driven movement after spinal cord ...
EINDHOVEN, The Netherlands, April 01, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback